Indomethacin Extended-Release Capsules USP, 75 mg, 100-count bottle, Rx only, Mfd. By: KVK-Tech, Inc., Newtown, PA, 18940, Made in USA, NDC 10702-016-01.
Published May 28, 2025 · Recall initiated: May 9, 2025
Summary
FDA records drug Class II recall D-0445-2025, published May 28, 2025 and initiated May 9, 2025. Recalling firm: KVK Tech, Inc.; Status: Ongoing; Reported quantity: 9107 bottles; Lot: Lot#: 18400A, Exp 7/31/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
cGMP deviations
What to do
Voluntary: Firm initiated · E-Mail
Get an email if INDOMETHACIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- INDOMETHACIN
- Manufacturer
- KVK Tech, Inc.
- Distributor
- Nationwide
- UPC
- 0310702016101
- Lot
- Lot#: 18400A, Exp 7/31/2027
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAIndomethacin Extended-Release Capsules, USP, 75 mg, 30 capsules (3 x 10 blister cards) per carton, Rx Only,June 11, 2025
- FDAAirsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in a)May 28, 2025
- FDAPhentermine Hydrochloride Capsules, USP 30mg, 100-count bottle, Rx Only, Mfd. By: KVK-Tech, Inc., Newtown, PA,May 28, 2025
- FDAIndomethacin Extended-Release Capsules, 75mg, 60-count bottles, Manufactured by: Glenmark PharmaceuticalsApril 16, 2025
- FDAIndomethacin Extended-Release Capsules, USP, 75 mg, packaged in a) 60-count bottle (NDC 68462-325-60) and b)September 4, 2024
- FDAIndomethacin 25mg Capsules, USP, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd.December 6, 2023
Questions about this recall
Was Indomethacin Extended-Release Capsules USP, 75 mg, 100-count bottle, Rx only, Mfd. By: KVK-Tech, Inc., Newtown, PA, 18940, Made in USA, NDC 10702-016-01. recalled?
Yes. FDA published recall D-0445-2025 on May 28, 2025. Reported hazard: cGMP deviations
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: INDOMETHACIN. UPC: 0310702016101.